Join
Live feed
·
PRReleasevia Quantisnow
Adagene Inc. logo
Incyte Corp. logo

Adagene Announces Clinical Collaboration with Incyte to Evaluate Muzastotug (ADG126) in Combination with Incyte's TGFßR2xPD-1 Bispecific Antibody (INCA33890) in Patients with Microsatellite Stable Colorectal Cancer (MSS CRC)

ByQuantisnow·Wall Street's wire, on your screen.
ADAG· Adagene Inc.INCY· Incyte Corp.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ADAG (Adagene Inc.), INCY (Incyte Corp.) and more on Quantisnow.